# OnCo record action-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/action-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "action-1", "NCT05477576" ;
  schema:name "ACTION-1"@en ;
  schema:description "Tests whether an actinium alpha-radioligand rescues neuroendocrine tumours after lutetium therapy fails."@en ;
  schema:url <https://onco.cc/trials/action-1/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05477576>, <https://jnm.snmjournals.org/content/67/8/1239> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  schema:startDate "2022-03-24" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:technologies <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  onco:drugs <https://onco.cc/drugs/ryz101/>, <https://onco.cc/drugs/lutathera/> .
